There is a particular moment that almost every funded MedTech founder encounters, usually when they
are deep into product development, chasing milestones, and managing investor expectations
simultaneously. It is the moment they realise that building a team is not simply a matter of posting a job
and selecting the best candidate. Done properly, recruitment is a discipline in its own right, and for
founders who have never had to do it at scale before, the reality of what it takes can come as a genuine
shock.
This is not a criticism. It is an observation drawn from years of working alongside brilliant, driven people
who are exceptional at what they do, but who underestimate what team building demands of them at
precisely the wrong moment.
The Founder Bottleneck: When the Engine Stalls
The founder is, in almost every early-stage MedTech business, the central driving force. They carry the
vision, maintain investor relationships, navigate regulatory complexity, and make the decisions that keep
the business moving forward. That is not a role that can simply be paused.
Yet when the time comes to grow the team, which is often triggered by a funding milestone or an
accelerating product roadmap, a significant portion of that same founder’s time suddenly gets absorbed by
recruitment. Writing job descriptions, sourcing candidates, reviewing CVs, conducting interviews,
following up, negotiating offers: all of it takes time, and none of it is time the founder had budgeted for.
The tension here is not just logistical. It is strategic. Every hour spent on recruitment activity is an hour not
spent on the things only the founder can do. Investor calls slip. Product decisions get delayed. The
momentum that made the business attractive to funders in the first place begins to slow, often at exactly the
moment when pace matters most.
What makes this harder is that recruitment, done well, is not a quick process. The temptation to rush it, to
fill roles fast and get back to the real work, is understandable but dangerous. A poor hire in a small team
does not just underperform in isolation. It creates friction, delays progress, and can cost far more to unwind
than the original hiring process would have cost to do properly. The pressure to move quickly and the need
to move carefully are in direct conflict, and the founder is caught in the middle.
The honest answer to this tension is not to hire faster. It is to think carefully about where the founder’s time
genuinely belongs, and to ensure that the recruitment process has the right support structure around it so
that quality is not sacrificed in the name of speed.
The Generalist Trap: Why Combining Roles Costs MoreThan It Saves
There is a second pattern that emerges frequently in early-stage MedTech businesses, and it tends to
surface slightly later, when the consequences have already started to compound. It begins with a
reasonable-sounding question: is there really enough work for two separate roles at this stage? The answer,
in the short term, often appears to be no. So the decision is made to combine them.
This instinct is not unreasonable. Headcount is expensive, and in a funded startup, every pound and dollar
carries weight. Hiring one person who can cover both bases seems like a practical, cost-conscious
approach. And in the very early days, it can appear to work.
The problem is what gets traded away in the process. When two distinct roles are collapsed into one, the
candidate pool shifts. Instead of attracting subject matter experts with deep domain knowledge in either
discipline, the search ends up targeting generalists who can do a bit of both. In some contexts, that
versatility is an asset. In MedTech product development, where regulatory standards are exacting and
technical depth genuinely matters, it tends to become a liability.
The jack-of-all-trades hire can carry the business through a certain phase. But as the product grows in
complexity, as the team around them expands, and as the demands of scaling become more specific, the
gaps in their expertise begin to show. What felt like a smart early decision starts to create friction:
decisions that should be made with authority get deferred, technical challenges that need specialist insight
take longer to resolve, and the team begins to feel the absence of the depth it never quite had.
By that point, the cost of fixing the problem is considerably higher than it would have been to hire
correctly from the outset. Specialist roles need to be recruited into a team that has already formed its habits
and structure. The original hire may need to be repositioned or replaced. And the business has often lost
time it cannot afford to lose.
The discipline here is to resist the short-term logic of role consolidation when the genuine need is for
depth. Expertise is not a luxury in MedTech product development. It is a prerequisite. And the decision to
dilute it rarely saves as much as it appears to.
What Gets Built in the Beginning Tends to Stay
There is a broader principle sitting behind both of these patterns, and it is worth naming directly. The
decisions made in the earliest stages of team building tend to shape the business for far longer than
founders typically expect. Structural habits form quickly. Role definitions, once established, are difficult to
revise without disruption. And the calibre of the people brought in during those formative months sets the
standard that everything else is measured against.
This is why the way a team gets built matters as much as the fact that it gets built at all. The instinct to
move fast, to save budget, to get someone in the door and get back to the real work: these are
understandable impulses, but they carry real risk in a sector where precision and expertise are fundamental
to success.
Founders who think carefully about team structure before they begin hiring, who protect their own time
and focus, and who resist the temptation to compromise on specialist depth, tend to build teams that hold
up under pressure and deliver on the timelines that matter. Those who do not often find themselves
revisiting those early decisions at a point when revisiting them is costly.
Getting recruitment right the first time is not about being cautious. It is about being deliberate. And in
MedTech, where the stakes are high and the margins for error are narrow, deliberate is exactly what it
needs to be.
